More than a year since the first outbreak in China in December 2019, most countries are still struggling to contain the COVID-19 pandemic. Mass antigen testing has been proposed as an instrument to mitigate the spread of the disease and allow the economy to re-open. We investigate the potential...

Empirical work described in this paper explains the daily evolution of the reproduction rate, R, and mobility for a large sample of countries, in terms of containment and public health policies. This is with a view to providing insight into the appropriate policy stance as countries prepare for...

We study the role of cost-benefit considerations in driving public acceptance of non-pharmaceutical interventions (NPIs) during the Covid-19 pandemic. In a large-scale online survey experiment with a representative sample of the US population, we introduce exogenous variation in the perceived...

Countries have employed a variety of non-pharmaceutical interventions (NPIs) in order to curtail the COVID-19 pandemic. However, the success of individual measures in reducing the number of infections remains controversial. This paper exploits a panel data set of 107 countries to estimate the...

In order to slow the spread of the CoViD-19 pandemic, governments around the world have enacted a wide set of policies limiting the transmission of the disease. Initially, these focused on non-pharmaceutical interventions; more recently, vaccinations and large-scale rapid testing have started to...

Decisions on public health measures to contain a pandemic are often based on parameters such as expected disease burden and additional mortality due to the pandemic. Both pandemics and nonpharmaceutical interventions to fight pandemics, however, produce economic, social, and medical costs. The...

Countries have employed a variety of non-pharmaceutical interventions (NPIs) in order to curtail the Covid-19 pandemic. However, the success of individual measures in reducing the number of infections remains controversial. This paper exploits a panel data set of 182 countries to estimate the...

Decisions on public health measures to contain a pandemic are often based on parameters such as expected disease burden and additional mortality due to the pandemic. Both pandemics and non-pharmaceutical interventions to fight pandemics, however, produce economic, social, and medical costs. The...

Government interventions to limit the spread of the COVID-19 disease have decreased mobility, which, in turn, impacts aggregate economic activity. Understanding mobility during the COVID-19 pandemic may serve as a proxy for understanding its economic impact. This study aims to examine the...

Without any intervention, the novel coronavirus would cost the U.S. economy over $9 trillion.